Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
    3.
    发明授权
    Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof 有权
    跳蚤头,神经线,后肠和恶臭小管核酸分子,蛋白质及其用途

    公开(公告)号:US08088903B2

    公开(公告)日:2012-01-03

    申请号:US11565729

    申请日:2006-12-01

    IPC分类号: C07H21/02 C07H21/04

    CPC分类号: C07K14/4359

    摘要: The present invention relates to flea head, nerve cord, hindgut and Malpighian tubule proteins; to flea head, nerve cord, hindgut and Malpighian tubule nucleic acid molecules, including those that encode such flea head, nerve cord, hindgut and Malpighian tubule proteins; to antibodies raised against such flea head, nerve cord, hindgut and Malpighian tubule proteins; and to compounds that inhibit flea head, nerve cord, hindgut and Malpighian tubule protein activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising proteins, nucleic acid molecules, antibodies, or protective compounds derived from proteins of the present invention as well as the use of such therapeutic compositions to protect animals from flea infestation. Also included in the present invention is the use of flea head, nerve cord, hindgut and Malpighian tubule proteins to derive inhibitory compounds.

    摘要翻译: 本发明涉及跳蚤头,神经根,后肠和马鞭状小管蛋白; 跳蚤头,神经线,后肠和马鞭状小管核酸分子,包括编码这种跳蚤头,神经线,后肠和马鞭状小管蛋白的那些; 针对这种跳蚤头,神经线,后肠和马鞭状小管蛋白质产生的抗体; 以及抑制跳蚤头,神经丝,后肠和马鞭状小管蛋白活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含衍生自本发明蛋白质的蛋白质,核酸分子,抗体或保护性化合物的治疗组合物,以及这些治疗组合物用于保护动物免于跳蚤侵染的治疗组合物。 本发明还包括使用跳蚤头,神经根,后肠和马鞭状小管蛋白来衍生抑制性化合物。

    Flea ecdysone and ultraspiracle nucleic acid molecules, proteins and uses thereof
    5.
    发明授权
    Flea ecdysone and ultraspiracle nucleic acid molecules, proteins and uses thereof 有权
    跳蚤蜕皮激素和超尖锐核酸分子,蛋白质及其用途

    公开(公告)号:US06489140B1

    公开(公告)日:2002-12-03

    申请号:US09435019

    申请日:1999-11-05

    IPC分类号: C12P2106

    摘要: The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.

    摘要翻译: 本发明涉及跳蚤蜕皮激素受体和超尖锐蛋白质; 跳蚤蜕皮激素受体和超尖锐核酸分子,包括那些编码这种跳蚤蜕皮激素受体和超尖锐蛋白质的分子; 针对这种跳蚤蜕皮激素受体和超尖锐蛋白的抗体; 以及抑制跳蚤蜕皮激素受体和/或超急性活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含抑制蜕皮激素受体和蜕皮激素之间结合的本发明蛋白质的保护性化合物的治疗组合物,以及这些治疗组合物用于保护动物免于跳蚤侵染的治疗组合物。

    Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof
    6.
    发明授权
    Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof 失效
    寄生虫蠕虫巨噬细胞迁移抑制因子蛋白质,核酸分子及其用途

    公开(公告)号:US06207158B1

    公开(公告)日:2001-03-27

    申请号:US08906480

    申请日:1997-08-05

    IPC分类号: A61K3900

    摘要: The present invention relates to parasitic helminth macrophage migration inhibitory factor (MIF) proteins; to parasitic helminth MIF nucleic acid molecules, including those that encode such MIF proteins; to antibodies raised against such MIF proteins; and to compounds that inhibit parasitic helminth MIF activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to protect animals from diseases caused by parasitic helminths.

    摘要翻译: 本发明涉及寄生蠕虫巨噬细胞迁移抑制因子(MIF)蛋白; 包括那些编码这种MIF蛋白的MIF核酸分子, 针对这种MIF蛋白产生的抗体; 以及抑制寄生蠕虫MIF活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含这些蛋白质,核酸分子,抗体和/或抑制性化合物的治疗组合物,以及这些治疗组合物用于保护动物免受寄生蠕虫引起的疾病的用途。

    Flea ultraspiracle nucleic acid molecules
    8.
    发明授权
    Flea ultraspiracle nucleic acid molecules 失效
    跳蚤超尖锐核酸分子

    公开(公告)号:US07667019B2

    公开(公告)日:2010-02-23

    申请号:US11697551

    申请日:2007-04-06

    IPC分类号: C07H21/04 A61K38/00

    摘要: The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.

    摘要翻译: 本发明涉及跳蚤蜕皮激素受体和超尖锐蛋白质; 跳蚤蜕皮激素受体和超尖锐核酸分子,包括那些编码这种跳蚤蜕皮激素受体和超尖锐蛋白质的分子; 针对这种跳蚤蜕皮激素受体和超尖锐蛋白的抗体; 以及抑制跳蚤蜕皮激素受体和/或超急性活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含抑制蜕皮激素受体和蜕皮激素之间结合的本发明蛋白质的保护性化合物的治疗组合物,以及这些治疗组合物用于保护动物免于跳蚤侵染的治疗组合物。

    Canine cox-2 nucleic acid molecules and uses thereof
    9.
    发明授权
    Canine cox-2 nucleic acid molecules and uses thereof 有权
    犬cox-2核酸分子及其用途

    公开(公告)号:US06638744B2

    公开(公告)日:2003-10-28

    申请号:US09919060

    申请日:2001-07-31

    IPC分类号: C12N902

    CPC分类号: A61K31/7088 C12N9/90

    摘要: The present invention relates to canine COX-1 and COX-2 proteins; to canine COX-1 and COX-2 nucleic acid molecules, including those that encode such COX-1 and COX-2 proteins, respectively; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes therapeutic compositions comprising such inhibitory compounds, particularly those that specifically inhibit COX-2 activity, as well as the use of such therapeutic compositions to treat animals.

    摘要翻译: 本发明涉及犬COX-1和COX-2蛋白; 涉及犬COX-1和COX-2核​​酸分子,包括分别编码这种COX-1和COX-2蛋白的那些; 针对这种蛋白质产生的抗体; 以及抑制这些蛋白质活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含这种抑制性化合物,特别是特异性抑制COX-2活性的抑制性化合物的治疗组合物,以及这些治疗组合物用于治疗动物的用途。